基于炎症与胰腺导管腺癌关联的新型药物靶点 - Suppr | 超能文献

Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.

作者信息

Saif Muhammad Wasif

出版信息

JOP. 2010 Jul 5;11(4):403-4; author reply 411.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.

JOP. 2010 Jul 5;11(4):403-4; author reply 411.

2

Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets.

JOP. 2010 May 5;11(3):199-202.

3

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.

Med Sci Monit. 2009 May;15(5):BR148-56.

4

Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.

Cancer Res. 2005 Feb 15;65(4):1316-24. doi: 10.1158/0008-5472.CAN-04-1626.

5

Inflammatory cytokines in human pancreatic cancer.

Cancer Lett. 2014 Apr 10;345(2):157-63. doi: 10.1016/j.canlet.2013.07.014. Epub 2013 Jul 20.

6

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.

Oncogene. 2007 Apr 26;26(19):2759-68. doi: 10.1038/sj.onc.1210076. Epub 2006 Nov 6.

7

L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.

Oncogene. 2010 Aug 26;29(34):4766-78. doi: 10.1038/onc.2010.230. Epub 2010 Jun 14.

8

Molecular mechanisms of pancreatic cancer and potential targets of treatment.

Scand J Gastroenterol. 2007 Mar;42(3):279-96. doi: 10.1080/00365520601106384.

9

Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature.

Hum Pathol. 2008 Oct;39(10):1548-51. doi: 10.1016/j.humpath.2008.01.021. Epub 2008 Jul 11.

10

Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.

JOP. 2010 Jul 5;11(4):328-30.

引用本文的文献

1

From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.

JOP. 2021;22(3):70-79. Epub 2021 May 31.